Showing results (1021-1030 of 3,790) with videos related to

Sort By:
Pageof 379
Oncoimmunology|July 3, 2015
Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8+ T-cell responses and immune memoryJunjie Wu, David J Waxman
Oncoimmunology|July 3, 2015
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapyJonathan Pol, Erika Vacchelli, Fernando Aranda, et al.
Oncoimmunology|July 3, 2015
Human derived dimerization tag enhances tumor killing potency of a T-cell engaging bispecific antibodyMahiuddin Ahmed, Ming Cheng, Irene Y Cheung, et al.
Oncoimmunology|July 3, 2015
STAT3 in arsenic lung carcinogenicityGang Chen
Oncoimmunology|July 3, 2015
CD20+ T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancerMarco de Bruyn, Valerie R Wiersma, Maartje C A Wouters, et al.
Oncoimmunology|July 29, 2016
HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapyJanet Kerstin Peper, Hans-Christian Bösmüller, Heiko Schuster, et al.
Oncoimmunology|July 29, 2016
Rapid dissemination of RET-transgene-driven melanoma in the presence of non-obese diabetic alleles: Critical roles of Dectin-1 and Nitric-oxide synthase type 2Emna Dabbeche-Bouricha, Luiza M Araujo, Masashi Kato, et al.
Oncoimmunology|July 29, 2016
GITR drives TH9-mediated antitumor immunityIl-Kyu Kim, Yeonseok Chung, Chang-Yuil Kang
Oncoimmunology|July 29, 2016
Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapyMaryann E Mikucki, Joseph J Skitzki, John G Frelinger, et al.
Oncoimmunology|July 29, 2016
Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1Erika Vacchelli, Yuting Ma, Elisa E Baracco, et al.
Pageof 379